In a column, Mr. Gingrich said Congress should ban exclusivity agreements between device makers and medical providers making their agreed-upon prices confidential. This makes “true price competition in the $153 billion medical-device marketplace impossible” and prices can be marked up “hundreds of percentage points,” Mr. Gingrich said.
He cited a 2009 report from McKinsey Global Institute showing hip implants cost 60 percent more in the United States than in several major European countries. In 2007, however, Congress failed to pass a bill that would have required implantable device makers to report sales data to the government.
Read the DOTmed report on medical devices.
Related Articles on Medical Devices:
5 Tips for Lowering Implant Costs at Orthopedic Surgery Centers
Device Makers’ Confidentiality Will Raise Costs, AHRMM Says
ETHOS Founder: Don’t Be Easily Allured by Medical Technology
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
